BRC Therapeutics Applauds Executive Order to Reclassify Cannabis
PR Newswire —
Positioned to Accelerate Downgrading of Cannabinoid Medicine Scheduling. MONTEREY, Calif., Dec. 19, 2025 /PRNewswire/ -- BRC Therapeutics (BRC), a pharmaceutical company developing proprietary therapeutics for neurological and inflammatory diseases, celebrates yesterday's landmark...